JAMA Otolaryngology–Head & Neck Surgery

Online First August 20, 2015

Original Investigation Association of Thyroid Nodule Size and Bethesda Class With Rate of Malignant Disease   Marcus J. Magister, MD; Irina Chaikhoutdinov, MD; Eric Schaefer, MS; et al JAMA Otolaryngol Head Neck Surg. Published online August 20, 2015. doi:10.1001/jamaoto.2015.1451 Long-term Functional Outcomes of Total Glossectomy With or Without Total Laryngectomy   Derrick T. Lin, MD; Bharat B. Yarlagadda, MD; Rosh K. V. Sethi, MD; et al JAMA Otolaryngol Head Neck Surg. Published online August 20, 2015. doi:10.1001/jamaoto.2015.1463 Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy   Eleonoor A. R. Theunissen, MD; Charlotte L. Zuur, MD, PhD; Katarzyna Jóźwiak, PhD; et al JAMA Otolaryngol Head Neck Surg. Published online August 20, 2015. doi:10.1001/jamaoto.2015.1515 Clinical Challenge Waxy Laryngeal Mass   Yu-Hsuan Lin, MD; Huai-Pao Lee, MD; Ming-Yee Lin, MD, PhD JAMA Otolaryngol Head Neck Surg. Published online August 20, 2015. doi:10.1001/jamaoto.2015.1491

! ORL via Alexandros G.Sfakianakis on Inoreader: Surface-optimized free flaps for complex facial defects after skin cancer

! ORL via Alexandros G.Sfakianakis on Inoreader

Surface-optimized free flaps for complex facial defects after skin cancer Aug 21st 2015, 03:24, by Marco Rainer Kesting, Colin MacIver, Craig J. Wales, Klaus-Dietrich Wolff, Christopher-Philipp Nobis, Nils Hagen Rohleder Advanced non-melanocytic skin cancer (NMSC) in the facial region causes extensive tissue loss, possibly coverable by local flaps. Remote free flaps are the reconstructive method of choice, despite disadvantages such as color and texture mismatch, and bulkiness with regard to facial skin.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

! ORL via Alexandros G.Sfakianakis on Inoreader: Expression of ezrin in oral squamous cell carcinoma: prognostic impact and clinicopathological correlations

! ORL via Alexandros G.Sfakianakis on Inoreader

Expression of ezrin in oral squamous cell carcinoma: prognostic impact and clinicopathological correlations Aug 21st 2015, 03:24, by Ali-Farid Safi, Hans-Joachim Nickenig, Daniel Rothamel, Matthias Zirk, Oliver Thiele, Andrea Grandoch, Martin Scheer, Max Zinser, Joachim Zöller, Uta Drebber, Matthias Kreppel There have been few investigations into the effects of ezrin expression in oral squamous cell carcinoma (OSCC). The aim of this study was to analyze the influence of ezrin expression on the prognosis of patients with OSCC.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions